Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-06-23
2000-08-29
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 9321, 424418, 435182, 435325, A61K 3170
Patent
active
061109029
ABSTRACT:
The present invention relates to the treatment of conditions associated with neuronal activity. Specifically, the invention is drawn to methods and compositions for administering adenosine to inhibit pain syndromes or epilepsy in a patient.
REFERENCES:
patent: 5573528 (1996-11-01), Aebischer et al.
patent: 5597827 (1997-01-01), Miller et al.
Loscher et al., "Which Animal Models Should Be Used in the Search for New Antiepileptic Drugs? A Proposal Based on Experimental and Clinical Considerations," Epilepsy Research, 2, 145-181 (1988).
Lothman et al., "Screening and Characterization of Antiepileptic Drugs with Rapidly Recurring Hippocampal Seizures in Rats," Epilepsy Research, 2, 367-379 (1988).
White, "Clinical Significance of Animial Seizure Models and Mechanism of Action Studies of Potential Antiepileptic Drugs," Epilepsia, 38(Suppl. 1), S9-S17 (1997).
Zurn et al., "Symptomatic Cell Therapies: Cells as Biological Minipumps," European Neurology, 36, 405-408 (1996).
Thomas et al. (eds.), Taber's Cyclopedic Medical Dictionary, 17th Edition/Illustrated, F. A. Davis Co., Philadelphia, PA, 1993, only pp. 660-662 supplied, see especially definition of epilepsy at p. 660, column 2.
Berkow et al. (eds.), a portion of Chapter 121 ("Seizure Disorders") in The Merck Manual of Diagnosis and Therapy, 16th Edition, Merck & Co. Rahway, NJ, 1992, only pp. 1436-1444 supplied.
Gomaa, "Characteristics of Analgesia Induced by Adenosine Triphosphate," Pharmacology & Toxicology, 61, 199-202 (1987).
Adami et al., 1995, Effects of repeated administration of selective adenosine A.sub.1 and A.sub.2A receptor agonists on pentylenetetrazole-induced convulsions in the rat, Eur. J. Pharmacol. 294:383-389.
Aebischer et al., 1994, Transplantation in Humans of Encapsulated Xenogeneic Cells Without Immunosupression, Transplant 58:1275-1277 (Dec. 1994).
Aebischer et al., 1991, Long-Term Cross-Species Brain Transplantation of a Polymer-Encapsulated Dopamine-Secreting Cell Line, Exp. Neurol. 111, 269-275.
Aebishcer et al., 1994, Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells, Exp. Neurol. 126:151-158.
Barone et al., 1989, Adenosine Receptor Prodrugs: Towards Kidney-Selective Dialkylxanthines, J. Pharmacol. Exp. Ther. 250:79-85 (Issue No. 1).
Chin, 1989, Adenosine Receptors in Brain: Neuromodulation and Role in Epilepsy, Ann. Neurol. 26:695-698 (Issue No. 6, Dec. 1989).
Collis and Hourani, 1993, Adenosine receptor subtypes, TIPS 14, 360-366 (Oct. 1993).
Concas et al., 1996, Differential Antagonism by the Selective A.sub.1 Adenosine Receptor Agonist CCPA of Seizures Induced by NMDA, Kainic Acid, and Domoic Acid, Neuroscience Research Communications 18:9-18 (Issue No. 1).
Corradetti et al., 1984, Adenosine Decreases Aspartate and Glutamate Release from Rat Hippocampal Slices, Eur. J. Pharmacol. 104:19-26.
Cottam et al., 1993, New Adenosine Kinase Inhibitors with Oral Antiinflammatory Activity: Synthesis and Biological Evaluation, J. Med. Chem. 36, 3424-3430 (Issue No. 22).
De Sarro et al., 1991, Anticonvulsant action of 2-chloroadenosine infected focally into the inferior colliculus and substantia nigra, European Journal of Pharmacology 194:145-152.
Dragunow, 1988, Purinergic Mechanisms in Epilepsy, Progr. Neurobiol. 31:85-108.
Dunwiddie and Worth, 1982, Sedative and Anticonvulsant Effects of Adenosine Analogs in Mouse and Rat.sup.1, J. Pharmacol. Exp. Therap. 220:70-76.
Fisher et al., 1991, Survival and Function of Intrastriatally Grafted Primary Fibroblasts Genetically Modified to Produce L-Dopa, Neuron 6:371-380 (Mar. 1991).
Fisher and Gage, 1994, Intracerebral transplantation: basic and clinical applications to the neostriatum, FASEB J. 8:489-496 (May 1994).
Foster et al., 1994, Regulation of Endogenous Adenosine Levels in the CNS: Potential for Therapy in Stroke, Epilepsy and Pain, Adv. Exp. Med. Biol. 370:427-430.
Franklin et al., 1988, Adenosine receptor activation blocks seizures induced by bicuculline methiodide in the rat prepiriform cortex, European Journal of Pharmacology 150:207-209.
Fredholm 1995, Adenosine Receptors in the Central Nervous System, NIPS 10:122-128, (Jun. 1995).
Gossen and Bujard, 1992, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA 89:5547-5551 (Jun. 1992).
Gossen et al., 1995, Transcriptional Activation by Tetracyclines in Mammalian Cells, Science 268:1766-1769 (Jun. 23, 1995).
Greene and Haas, 1991, The Electrophysiology of Adenosine in the Mammalian Central Nervous System, Progr. Neurobiol. 36:;329-341.
Guieu et al., 1996, Adenosine and the Nervous System: Clinical Implications, Clinical Neuropharmacology 19:459-474 (Issue No. 6).
Herberg et al., 1993, Effect of an Adenosine A.sup.1 Agonist Injected Into Substantia Nigra on Kindling of Epileptic Seizures and Convulsion Duration, Pharmacol. Biochem. Behav. 44:113-117.
Jiao et al., 1993, Long-term correction of rat model of Parkinson's disease by gene therapy, Nature 362:450-453 (Apr. 1, 1993).
Maillard et al., 1994, Adenosine Receptor Prodrugs: Synthesis and Biological Activity of Derivatives of Potent, A.sub.1 -Selective Agonists, J. Pharm. Sci. 83:46-53 (Issue #1, Jan. 1994).
Maitre et al., 1974, Protective Effect of Adenosine and Nicotinamide Against Audiogenic Seizure, Biochemical Pharmacology 23:2807-2816.
McNally et al., 1997, Cloning and Expression of the Adenosine Kinase Gene from Rat and Human Tissue, Biochem. Biophys. Res. Comm. 231:645-650 (Issue No. 3).
Nellen and Lichtenstein, 1993, What makes an mRNA anti-sense-itive, TIBS 18:419-423 (Nov. 1993).
Palmer and Stiles, 1995, Review: Neurotransmitter Receptors VII:Adenosine Receptors, Neuropharmacology 34:683-94 (Issue No. 7).
Petersen, 1991, Selective protection by adenosine receptor agonists against DMCM-induced seizures, European Journal of Pharmacology 195:261-265.
Pospisil et al., 1993, Noradrenaline Reduces Cardiovascular Effects of the Combined Dipyridamole and AMP Administration but Preserves Radioprotective Effects of these Drugs on Hematopoiesis in Mice, Physiol. Res. 42:333-340.
Sabate et al., 1995, Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses, Nature Genetics 9:256-260 (Mar. 1995).
Sagen et al., (Jun.) 1993, Transplants of Immunologically Isolated Xenogeneic Chromaffin Cells Provide a Long-Term Source of Pain-reducing Neuroactive Substances, J. Neurosci. 13:2415-2423 (No. 6).
Sagot et al., 1995, Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse, Eur. J. Neurosci. 7:1313-1322.
Sawynok and Sweeney, 1989, The Role of Purines in Nocicption, Neuroscience 32:557-569(No. 3).
Singh et al., 1996, Cloning and characterzation of cDNA for adenosine kinase from mammalian (Chinese hamster, mouse, human and rat) species; High frequency mutants of Chinese hamster ovary cells involve structural alterations in the gene, Eur. J. Biochem. 241:564-571.
Spychala et al., 1996, Cloning of human adenosine kinase cDNA: Sequence similarity to microbial ribokinases and fructokinases, Proc. Nat. Acad. Sci. USA 93:1232-1237 (Feb. 1996).
Suhr and Gage, 1993, Gene Therapy for Neurologic Disease, Arch. Neurol. 50:1252-1258 (Nov. 1993).
Tai and Sun, 1993, Microencapsulation of recombinant cells: a new delivery system for gene therapy, FASEB J. 7:1061-1069 (Aug. 1993).
Thompson et al., 1993, Presynaptic inhibition in the hippocampus, TINS 16:222-227 (Issue No. 6).
Ulrich and Huguenard, 1995, Purinergic Inhibition of GABA and Glutamate Release in the Thalamus: Implications for Thalamic Network Activity, Neuron 15:909-918 (Oct. 1995).
Valerio et al., 1985, Adenosine deaminase: characterization and expression of a gene with a remarkable promoter, EMBO J. 4:437-433 (Issue No. 2).
Voits and Frey, 1994, Stimulation-Dependent Effect of Antiepileptic Drugs in Amygdala Kindled Rats on Both Seizure Score and Duration of Afterdischarges, Pharmacol. Toxicol. 75:54-61.
Von Lubitz et al., 1994, Chronic adenosine A.sub.1 recept
Boison Detlev
Mohler Hanns
Crane L. Eric
Geist Gary
LandOfFree
Method for the inhibition of neuronal activity leading to a foca does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the inhibition of neuronal activity leading to a foca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the inhibition of neuronal activity leading to a foca will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249997